心臓再同期療法の世界市場レポート 2025年

心臓再同期療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で87億7,000万米ドルに成長します。予測期間の成長は、心不全や心疾患の有病率の増加、高齢者人口の増加、心血管疾患の罹患率の増加、CRT治療の必要性、ペースメーカーや除細動器治療の改善、CRT治療に対する意識の高まりなどに起因すると考えられます。予測期間における主な動向としては、従来のペースメーカーに対するCRT-Dデバイスの採用、先端技術の統合、CRT療法の拡大、人工知能の統合、機械学習の採用などが挙げられます。

心血管疾患の有病率の上昇は、心臓再同期療法（CRT）市場の成長を促進すると予想されます。心血管疾患（CVD）には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。CVDの発生率は、高齢化、不健康なライフスタイル、タバコの多用、座りがちな生活、食生活の乱れなどの要因により増加しています。心臓再同期療法は、同期化された電気インパルスを通じて心臓の収縮の協調を改善することにより、心不全のような症状の治療に役立ちます。例えば、2024年9月、米国の州保健機関であるミネソタ州保健局のデータによると、2023年にはミネソタ州の成人の約30％が高血圧であると報告し、約140万人が影響を受けていることが明らかになりました。2022年には、高血圧性疾患が同州における1万4,225人の死亡の一因となり、死亡者全体の約28％を占めました。このように、心血管疾患の有病率の増加が心臓再同期療法市場の需要を牽引しています。

ヘルスケア支出の増加が心臓再同期療法（CRT）市場拡大の原動力となっています。ヘルスケア支出とは、特定の期間におけるヘルスケア商品およびサービスに対する総支出のことで、一般的には国または機関レベルでの支出を指します。ヘルスケアへの投資が増加することで、心臓再同期療法分野の研究開発が促進され、技術の進歩、治療へのアクセスの改善、ヘルスケアシステムのより包括的なアプローチにつながります。例えば、2023年5月、英国国家統計局は、ヘルスケア支出の名目9.4％増、実質9.7％増を報告しました。2021年の英国の総ヘルスケア支出は3,672億5,000万米ドル（2,807億英ポンド）で、そのうち医薬品費は518億4,000万米ドル（396億英ポンド）を占めました。2021年には予防医療への支出も急増し、459億3,000万米ドル（351億英ポンド）に達しました。さらに2024年9月、米国を拠点にABAセラピーサービスを提供するクロス・リバー・セラピー社は、米国の製薬業界の売上高が5,500億米ドルに達し、2021年には米国人が医薬品に5,769億米ドルを支出したと報告しました。予測によれば、この支出は2025年までに6050億～6,350億米ドルに増加するといいます。その結果、ヘルスケア支出の増加が心臓再同期療法市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓再同期療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心臓再同期療法市場：成長率分析
• 世界の心臓再同期療法市場の実績：規模と成長, 2019-2024
• 世界の心臓再同期療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓再同期療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓再同期療法市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓再同期療法（CRT）- 除細動器
• 心臓再同期療法（CRT）- ペースメーカー
• 世界の心臓再同期療法市場年齢別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 44歳未満
• 45～64歳
• 65～84歳
• 85歳以上
• 世界の心臓再同期療法市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 心臓ケアセンター
• 外来手術センター
• 世界の心臓再同期療法市場、心臓再同期療法（CRT）-除細動器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルチャンバーCRT-D
• デュアルチャンバーCRT-D
• トリプルチャンバーCRT-D
• 両心室CRT-D
• 世界の心臓再同期療法市場、心臓再同期療法（CRT）-ペースメーカーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルチャンバーCRT-P
• デュアルチャンバーCRT-P
• トリプルチャンバーCRT-P
• 両心室CRT-P

第7章 地域別・国別分析

• 世界の心臓再同期療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓再同期療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓再同期療法市場：競合情勢
• 心臓再同期療法市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lepu Medical Technology（Beijing）Co. Ltd.
• Integer Holdings Corporation
• Merit Medical Systems Inc.
• LivaNova PLC
• MicroPort Scientific Corporation
• Sorin Group
• Berlin Heart GmbH
• EBR Systems Inc.
• Corvia Medical Inc.
• Recor Medical
• Jarvik Heart Inc.
• Cardiac Dimensions Inc.
• Farapulse Inc.
• Osypka Medical GmbH
• Japan Medical Device Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓再同期療法市場2029：新たな機会を提供する国
• 心臓再同期療法市場2029：新たな機会を提供するセグメント
• 心臓再同期療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cardiac resynchronization therapy (CRT) is a treatment for heart failure aimed at synchronizing the contractions of the heart's ventricles. This therapy utilizes a biventricular pacemaker to administer electrical impulses to the heart muscle, thereby promoting a more coordinated rhythm of ventricular contractions. It has the potential to alleviate symptoms of heart failure, such as shortness of breath and fatigue, while also enhancing overall cardiac function.

The primary types of cardiac resynchronization therapy include cardiac resynchronization therapy (CRT)-defibrillator and cardiac resynchronization therapy (CRT)-pacemaker. A cardiac resynchronization therapy (CRT) defibrillator is a medical device designed to regulate heartbeats and deliver electrical shocks when irregular heart rhythms occur. These devices are utilized across various age groups, including patients below 44 years, 45-64 years, 65-84 years, and those aged above 85 years, by hospitals, cardiac care centers, and ambulatory surgical centers.

The cardiac resynchronization therapy market research report is one of a series of new reports from The Business Research Company that provides cardiac resynchronization therapy market statistics, including cardiac resynchronization therapy industry global market size, regional shares, competitors with a cardiac resynchronization therapy market share, detailed cardiac resynchronization therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac resynchronization therapy industry. This cardiac resynchronization therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac resynchronization therapy market size has grown strongly in recent years. It will grow from $6.29 billion in 2024 to $6.74 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth in the geriatric population, an increased incidence of heart failure, growth in investments in R&D for CRT device innovation, increased awareness about the therapy's benefits, physician training programs, and competitive landscape dynamics.

The cardiac resynchronization therapy market size is expected to see strong growth in the next few years. It will grow to $8.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the increasing prevalence of heart failure and cardiac disorders, growth in the geriatric population, a higher incidence of cardiovascular diseases, the need for CRT therapy, improvements in pacemakers and defibrillator treatment, and increasing awareness about CRT therapy. Major trends in the forecast period include the adoption of CRT-D devices over traditional pacemakers, the integration of advanced technology, expansion of CRT therapy, the integration of artificial intelligence, and the adoption of machine learning.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the cardiac resynchronization therapy (CRT) market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. The incidence of CVD is increasing due to factors such as aging populations, unhealthy lifestyles, high tobacco use, sedentary behavior, and poor dietary habits. Cardiac resynchronization therapy helps treat conditions like heart failure by improving the coordination of the heart's contractions through synchronized electrical impulses. For example, in September 2024, data from the Minnesota Department of Health, a US-based state health agency, revealed that approximately 30% of adults in Minnesota reported having high blood pressure in 2023, affecting nearly 1.4 million people. In 2022, hypertensive diseases were a contributing cause in 14,225 deaths in the state, accounting for almost 28% of all fatalities. As such, the growing prevalence of cardiovascular diseases is driving the demand for cardiac resynchronization therapy market.

The growing healthcare expenditure is expected to drive the expansion of the cardiac resynchronization therapy (CRT) market. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, typically on a national or institutional level. Increased investment in healthcare can foster research and development in the field of cardiac resynchronization therapy, leading to advancements in technology, improved access to therapy, and a more comprehensive approach to healthcare systems. For example, in May 2023, the UK's Office for National Statistics reported a 9.4% nominal increase and a 9.7% practical increase in healthcare spending. In 2021, the UK's total healthcare spending was $367.25 billion (£280.7 billion), with pharmaceutical costs accounting for $51.84 billion (£39.6 billion). Spending on preventative care also surged in 2021, reaching $45.93 billion (£35.1 billion). Additionally, in September 2024, Cross River Therapy, a US-based provider of ABA therapy services, reported that the US pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021. Projections suggest this spending will rise to $605-$635 billion by 2025. As a result, the increasing healthcare expenditure is driving the growth of the cardiac resynchronization therapy market.

Leading companies in the cardiac resynchronization therapy market are concentrating on the development of implantable devices to enhance treatment outcomes for heart failure patients. Implantable devices in CRT synchronize the contractions of the heart's ventricles, improving pumping efficiency and managing heart failure symptoms. For instance, MicroPort Scientific Corporation launched the GALI SonR cardiac resynchronization therapy and defibrillation device (CRT-D) and the Navigo 4LV left ventricular pacing leads in Japan in February 2024. This innovative CRT-D device incorporates the first and only CRT hemodynamic sensor, designed to automatically optimize patients on a weekly basis, even during physical activity, thus ensuring real-life optimization. The clinically proven SonR algorithm has demonstrated a 35% reduction in the risk of heart failure hospitalization, contributing to the well-being and safety of CRT-D patients.

Major companies operating in the cardiac resynchronization therapy market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Integer Holdings Corporation, Merit Medical Systems Inc., LivaNova PLC, MicroPort Scientific Corporation, Sorin Group, Berlin Heart GmbH, EBR Systems Inc., Corvia Medical Inc., Recor Medical, Jarvik Heart Inc., Cardiac Dimensions Inc., Farapulse Inc., Osypka Medical GmbH, Japan Medical Device Corporation, Imricor Medical Systems Inc., Vascular Dynamics Inc., Svelte Medical Systems, Aleva Neurotherapeutics, BioSig Technologies Inc.

North America was the largest region in the cardiac resynchronization therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac resynchronization therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac resynchronization therapy market consists of revenues earned by entities by providing services such as patient evaluation and diagnosis, device implantation procedures, device programming, follow-up care, management of complications, patient education, and collaborative care involving a multidisciplinary team. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac resynchronization therapy market also includes sales of pacemakers or defibrillators, leads, programmers, accessories, diagnostic tools, patient monitoring devices, and educational materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Resynchronization Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac resynchronization therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac resynchronization therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac resynchronization therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator; Cardiac Resynchronization Therapy (CRT)-Pacemaker
• 2) By Age: Below 44 Years; 45-64 Years; 65-84 Years; Above 85 Years
• 3) By End-Use: Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers
• Subsegments:
• 1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D; Dual-Chamber CRT-D; Triple-Chamber CRT-D; Bi-Ventricular CRT-D
• 2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P; Dual-Chamber CRT-P; Triple-Chamber CRT-P; Bi-Ventricular CRT-P
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; Biotronik SE & Co. KG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Resynchronization Therapy Market Characteristics

3. Cardiac Resynchronization Therapy Market Trends And Strategies

4. Cardiac Resynchronization Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Resynchronization Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Resynchronization Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Resynchronization Therapy Market Growth Rate Analysis
• 5.4. Global Cardiac Resynchronization Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Resynchronization Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Resynchronization Therapy Total Addressable Market (TAM)

6. Cardiac Resynchronization Therapy Market Segmentation

• 6.1. Global Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Resynchronization Therapy (CRT)-Defibrillator
• Cardiac Resynchronization Therapy (CRT)-Pacemaker
• 6.2. Global Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Below 44 Years
• 45-64 Years
• 65-84 Years
• Above 85 Years
• 6.3. Global Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Cardiac Care Centers
• Ambulatory Surgical Centers
• 6.4. Global Cardiac Resynchronization Therapy Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT)-Defibrillator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chamber CRT-D
• Dual-Chamber CRT-D
• Triple-Chamber CRT-D
• Bi-Ventricular CRT-D
• 6.5. Global Cardiac Resynchronization Therapy Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT)-Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chamber CRT-P
• Dual-Chamber CRT-P
• Triple-Chamber CRT-P
• Bi-Ventricular CRT-P

7. Cardiac Resynchronization Therapy Market Regional And Country Analysis

• 7.1. Global Cardiac Resynchronization Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Resynchronization Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Resynchronization Therapy Market

• 8.1. Asia-Pacific Cardiac Resynchronization Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Resynchronization Therapy Market

• 9.1. China Cardiac Resynchronization Therapy Market Overview
• 9.2. China Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Resynchronization Therapy Market

• 10.1. India Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Resynchronization Therapy Market

• 11.1. Japan Cardiac Resynchronization Therapy Market Overview
• 11.2. Japan Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Resynchronization Therapy Market

• 12.1. Australia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Resynchronization Therapy Market

• 13.1. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Resynchronization Therapy Market

• 14.1. South Korea Cardiac Resynchronization Therapy Market Overview
• 14.2. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Resynchronization Therapy Market

• 15.1. Western Europe Cardiac Resynchronization Therapy Market Overview
• 15.2. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Resynchronization Therapy Market

• 16.1. UK Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Resynchronization Therapy Market

• 17.1. Germany Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Resynchronization Therapy Market

• 18.1. France Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Resynchronization Therapy Market

• 19.1. Italy Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Resynchronization Therapy Market

• 20.1. Spain Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Resynchronization Therapy Market

• 21.1. Eastern Europe Cardiac Resynchronization Therapy Market Overview
• 21.2. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Resynchronization Therapy Market

• 22.1. Russia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Resynchronization Therapy Market

• 23.1. North America Cardiac Resynchronization Therapy Market Overview
• 23.2. North America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Resynchronization Therapy Market

• 24.1. USA Cardiac Resynchronization Therapy Market Overview
• 24.2. USA Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Resynchronization Therapy Market

• 25.1. Canada Cardiac Resynchronization Therapy Market Overview
• 25.2. Canada Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Resynchronization Therapy Market

• 26.1. South America Cardiac Resynchronization Therapy Market Overview
• 26.2. South America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Resynchronization Therapy Market

• 27.1. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Resynchronization Therapy Market

• 28.1. Middle East Cardiac Resynchronization Therapy Market Overview
• 28.2. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Resynchronization Therapy Market

• 29.1. Africa Cardiac Resynchronization Therapy Market Overview
• 29.2. Africa Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Resynchronization Therapy Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Resynchronization Therapy Market Competitive Landscape
• 30.2. Cardiac Resynchronization Therapy Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Resynchronization Therapy Market Other Major And Innovative Companies

• 31.1. Lepu Medical Technology (Beijing) Co. Ltd.
• 31.2. Integer Holdings Corporation
• 31.3. Merit Medical Systems Inc.
• 31.4. LivaNova PLC
• 31.5. MicroPort Scientific Corporation
• 31.6. Sorin Group
• 31.7. Berlin Heart GmbH
• 31.8. EBR Systems Inc.
• 31.9. Corvia Medical Inc.
• 31.10. Recor Medical
• 31.11. Jarvik Heart Inc.
• 31.12. Cardiac Dimensions Inc.
• 31.13. Farapulse Inc.
• 31.14. Osypka Medical GmbH
• 31.15. Japan Medical Device Corporation

32. Global Cardiac Resynchronization Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Resynchronization Therapy Market

34. Recent Developments In The Cardiac Resynchronization Therapy Market

35. Cardiac Resynchronization Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Resynchronization Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Resynchronization Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Resynchronization Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer